These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1496778)

  • 1. Preliminary development of a live drug-controlled vaccine against bovine babesiosis using the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Gannon P
    Vet Parasitol; 1992 May; 42(3-4):179-88. PubMed ID: 1496778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assays for drug resistance in Babesia divergens using the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Parr SL
    Res Vet Sci; 1992 Jan; 52(1):126-8. PubMed ID: 1553433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rapid passage in the gerbil (Meriones unguiculatus) on the course of infection of the bovine piroplasm Babesia divergens in splenectomised calves.
    Murphy TM; Gray JS; Langley RJ
    Res Vet Sci; 1986 May; 40(3):285-7. PubMed ID: 3738223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific resistance to Babesia divergens in the Mongolian gerbil (Meriones unguiculatus).
    Langley RJ; Gray JS
    Int J Parasitol; 1989 May; 19(3):265-9. PubMed ID: 2759766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity to Babesia divergens in Mongolian gerbils, Meriones unguiculatus, using culture-derived immunogens.
    Winger CM; Canning EU; Culverhouse JD
    Vet Parasitol; 1987 Dec; 26(1-2):43-53. PubMed ID: 3439004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of Babesia divergens in the gerbil, Meriones unguiculatus.
    Gray JS
    Res Vet Sci; 1983 Nov; 35(3):318-24. PubMed ID: 6665315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against bovine babesiosis with drug-controlled live parasites.
    Gray JS; Langley RJ; Brophy PO; Gannon P
    Vet Rec; 1989 Sep; 125(14):369-72. PubMed ID: 2683338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation of Babesia divergens from jirds as a live vaccine for cattle.
    Hentrich B; Böse R
    Int J Parasitol; 1993 Sep; 23(6):771-6. PubMed ID: 8300287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved disease resistance after Babesia divergens vaccination.
    Edelhofer R; Kanout A; Schuh M; Kutzer E
    Parasitol Res; 1998; 84(3):181-7. PubMed ID: 9521006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diminazene block treatment on live redwater vaccine reactions.
    Combrink MP; Troskie PC
    Onderstepoort J Vet Res; 2004 Jun; 71(2):113-7. PubMed ID: 15373333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
    Pudney M; Gray JS
    J Parasitol; 1997 Apr; 83(2):307-10. PubMed ID: 9105316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprophylactic activity of imidocarb, diminazene and oxytetracycline against Babesia bovis and B. bigemina.
    Kuttler KL; Johnson LW
    Vet Parasitol; 1986 Jun; 21(2):107-18. PubMed ID: 3739203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Babesia divergens: activity of long-acting oxytetracycline in the gerbil, Meriones unguiculatus].
    Losson B; Patz R
    Ann Rech Vet; 1989; 20(4):501-7. PubMed ID: 2619208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of imidocarb dipropionate prophylaxis on the infectivity and immunogenicity of a Babesia bovis vaccine in cattle.
    de Vos AJ; Dalgliesh RJ; McGregor W
    Aust Vet J; 1986 Jun; 63(6):174-8. PubMed ID: 3767795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of Babesia divergens in Tunisia.
    Bouattour A; Darghouth MA
    Vet Parasitol; 1996 May; 63(1-2):161-5. PubMed ID: 8792588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of effective living vaccines against bovine babesiosis--the longest field trial?
    Callow LL; Dalgliesh RJ; de Vos AJ
    Int J Parasitol; 1997 Jul; 27(7):747-67. PubMed ID: 9279577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual effect of antibabesial drugs on the live redwater blood vaccines.
    Combrink MP; Troskie PC; De Waal DT
    Ann N Y Acad Sci; 2002 Oct; 969():169-73. PubMed ID: 12381585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunogenicity and virulence between Babesia bigemina parasites from continuous culture and from a splenectomised calf.
    Jorgensen WK; De Vos AJ; Dalgliesh RJ
    Aust Vet J; 1989 Nov; 66(11):371-2. PubMed ID: 2619652
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitigation of the response of Friesian calves to live Babesia bovis vaccine by treatment with long acting oxytetracycline.
    Pipano E; Krigel Y; Markovics A; Rubinstein E; Frank M
    Vet Rec; 1985 Oct; 117(16):413-4. PubMed ID: 4071930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.